Skip to main content
High RiskFDAfda-F-1573-2017UNDECLARED ALLERGEN

Great Shake Plus Fortified Nutrition, Soy Formula, Strawberry Artificially Flavored, Packaged in 4 fl oz. (118 mL). Store Frozen.

Category
Units Affected
25,774
Recall Date
February 22, 2017
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1573-2017.

Hormel Foods is recalling Great Shake and Great Shake Plus, fortified Nutrition drinks, due to presence of undeclared milk.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1573-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hormel Foods Corporation or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1573-2017.

Hormel Foods Corporation

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hormel Foods Corporation Recall FAQ

Hormel Foods Corporation is the subject of a produce safety report: Great Shake Plus Fortified Nutrition, Soy Formula, Strawberry Artificially Flavored, Packaged in 4 fl oz. (118 mL). Store Frozen.. The notice was published on February 22, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 25,774 units are potentially affected.